ZEN-3411, identified by its CAS number 1952264-36-6, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds like ZEN-3411 are typically evaluated for their biological activity, pharmacokinetics, and safety profiles. It is often studied for its interactions with biological targets, which may include enzymes or receptors relevant to disease mechanisms. The compound's efficacy and safety are assessed through various in vitro and in vivo studies, contributing to its potential as a drug candidate. Additionally, ZEN-3411 may exhibit specific physicochemical properties, such as melting point and stability under different conditions, which are crucial for formulation and development. As research progresses, detailed information regarding its mechanism of action and therapeutic potential continues to evolve, making it a subject of interest in pharmaceutical research.

ZEN-3411 is a BET inhibitor for BRD4(BD1), BRD4(BD2) and BRD4(BD1BD2), respectively. ZEN-3411 can be used to form PROTACs to induce degradation of BRD4.

ZEN-3411

1952264-36-6: ZEN-3411, identified by its CAS number 1952264-36-6, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds like ZEN-3411 are typically evaluated for their biological activity, pharmacokinetics, and safety profiles. It is often studied for its interactions with biological targets, which may include enzymes or receptors relevant to disease mechanisms. The compound's efficacy and safety are assessed through various in vitro and in vivo studies, contributing to its potential as a drug candidate. Additionally, ZEN-3411 may exhibit specific physicochemical properties, such as melting point and stability under different conditions, which are crucial for formulation and development. As research progresses, detailed information regarding its mechanism of action and therapeutic potential continues to evolve, making it a subject of interest in pharmaceutical research.

<p>ZEN-3411 is an BET inhibitor that inhibits BRD4(BD1), BRD4(BD2), and BRD4(BD1BD2) and suppresses the growth of tumor cells overproducing BET proteins.</p>

CAS 1952264-36-6

ZEN-3411

ZEN-3411

Ref: 54-BUP08768

ZEN-3411

Ref: TM-T13393